You are here: Industry Insights > API

News List

Alembic Pharma gets EIR from US FDA for Karakhadi API facility expresspharma
March 18, 2020
Alembic Pharmaceuticals on Tuesday said it has received an EIR from the US health regulator after inspection of its active pharmaceutical ingredient (API) facility at Karakhadi in Gujarat.
No shortage of APIs and formulations in the country, says Government expresspharma
March 17, 2020
The National Pharmaceutical Pricing Authority (NPPA) has been assured by pharma industry body Indian Drugs Manufacturing Association (IDMA) ...
India should reduce dependence on China for APIs, says industry insider europeanpharmaceuticalreview
March 16, 2020
According to a report, supply disruption scares and price hikes due to COVID-19 are a ‘wake-up call’ for India to reduce its dependence on China for APIs.
Sufficient medicine raw materials, formulations available to meet coronavirus outbreak: NPPA expresspharma
March 13, 2020
NPPA Chairman Shubhra Singh met representatives of pharmaceutical industry associations on the issue of availability of critical APIs.
API Supply: COVID-19 Industry Update contractpharma
March 09, 2020
A breakdown of manufacturing facilities making active pharmaceutical ingredients (APIs) for U.S. market.
Oil and hydrogel mix effective for precise dosing of medicine europeanpharmaceuticalreview
March 04, 2020
Researchers have developed a new mixture of oil and hydrogel that releases drugs in a controlled fashion, preventing overdosing.
Almac Awarded $200,000 BMGF Grant ContractPharma
December 11, 2019
Will work to develop novel biocatalytic routes to Etonorgestrel and Levonorgestrel APIs.
Forging Ahead-About Chinese Pharmaceutical Enterprises’ Passing of WHO PQ PharmaSources/zhulikou431
December 03, 2019
As a significant part of the world pharmaceutical industry, the Chinese pharmaceutical industry has undoubtedly been deeply involved in each link of the cooperation and ...
The injection consistency evaluation may be comprehensively implemented as the NMPA takes frequent actions (2) PharmaSources/zhulikou431
November 14, 2019
Point 1: Applicants must comprehensively understand the products applied for
C2 PHARMA Continues to Expand API Portfolio with Digoxin Micronized Grade, Homatropine Hydrobromide and Multiple Products Under Tech Transfer and Development En-CPhI.CN
November 06, 2019
C2 PHARMA s.a.r.l. (C2P) continues to build its active pharmaceutical ingredient (API) and botanical extracts product portfolio.